Literature DB >> 3781491

Pulmonary veno-occlusive disease. A report of four cases.

P S Hasleton, J W Ironside, J S Whittaker, W Kelly, C Ward, G S Thompson.   

Abstract

Four cases of pulmonary veno-occlusive disease are described. Two patients, who were brothers, had respiratory tract infections. The third patient had chronic active hepatitis and coeliac disease suggesting an abnormality of the immune system; the fourth patient had no obvious cause but presented initially with systemic hypertension. Three of the cases had been diagnosed initially as primary pulmonary hypertension either on open lung biopsy or clinically. In all cases the pulmonary arteries were abnormal with medial hypertrophy, intimal fibrosis and, in some cases, thrombosis in elastic pulmonary arteries. These findings suggest that pulmonary veno-occlusive disease is not confined to veins and should be considered as a widespread pulmonary vascular disease. The range of aetiological factors indicate that it should not be considered as a single disease entity.

Entities:  

Mesh:

Year:  1986        PMID: 3781491     DOI: 10.1111/j.1365-2559.1986.tb02591.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

Review 1.  Celiac Disease and Thrombotic Events: Systematic Review of Published Cases.

Authors:  Nikola Pantic; Ivana Pantic; Dorde Jevtic; Vanajakshi Mogulla; Stevan Oluic; Momcilo Durdevic; Terri Nordin; Mladen Jecmenica; Tamara Milovanovic; Tatjana Gavrancic; Igor Dumic
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

2.  Severe pulmonary vascular change in patients dying with right ventricular failure after heart transplantation.

Authors:  P S Hasleton; N H Brooks
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

3.  Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension.

Authors:  I Chazova; J E Loyd; V S Zhdanov; J H Newman; Y Belenkov; B Meyrick
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.